Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Mizuno, Shohei
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Uchino K
,
Mizuno S
,
Mizutani M
,
Horio T
,
Hanamura I
,
J Espinoza L
,
Matsuo K
,
Onizuka M
,
Kashiwase K
,
Morishima Y
, et al.
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.
Transpl Immunol. 2016.
PubMed
Google Scholar
Katsuyama N
,
Kawase T
,
Barakat C
,
Mizuno S
,
Tomita A
,
Ozeki K
,
Nishio N
,
Sato Y
,
Kajiya R
,
Shiraishi K
, et al.
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
Nagoya J Med Sci. 2023;85(4):779-796.
PubMed
Google Scholar
P
Shibata S
,
Arai Y
,
Kondo T
,
Mizuno S
,
Yamasaki S
,
Akasaka T
,
Doki N
,
Ota S
,
Maruyama Y
,
Matsuoka K-I
, et al.
Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia.
Cytotherapy. 2024.
PubMed
Google Scholar
O
Sakurai M
,
Mori T
,
Kato K
,
Kanaya M
,
Mizuno S
,
Shiratori S
,
Wakayama T
,
Uchida N
,
Kobayashi H
,
Kubo K
, et al.
Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
Bone Marrow Transplant. 2021.
PubMed
Google Scholar
I
Shimazu Y
,
Mizuno S
,
Fuchida S-I
,
Suzuki K
,
Tsukada N
,
Hanagaishi A
,
Itagaki M
,
Kataoka K
,
Kako S
,
Sakaida E
, et al.
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
Cancer Sci. 2021.
PubMed
Google Scholar
F
Kamijo K
,
Shimomura Y
,
Shinohara A
,
Mizuno S
,
Kanaya M
,
Usui Y
,
Kim S-W
,
Ara T
,
Mizuno I
,
Kuriyama T
, et al.
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol. 2023.
PubMed
Google Scholar
Mizuno S
,
Takami A
,
Kawamura K
,
Shimomura Y
,
Arai Y
,
Konuma T
,
Ozawa Y
,
Sawa M
,
Ota S
,
Takahashi S
, et al.
Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.
Transplant Cell Ther. 2022.
PubMed
Google Scholar
E
Yamasaki S
,
Mizuno S
,
Iwasaki M
,
Seo S
,
Uchida N
,
Shigesaburo M
,
Nakano N
,
Ishiwata K
,
Uehara Y
,
Eto T
, et al.
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.
Ann Hematol. 2023.
PubMed
Google Scholar
D
Barakat C
,
Inagaki Y
,
Mizuno S
,
Nishio N
,
Katsuyama N
,
Sato Y
,
Kobayashi M
,
Ozeki K
,
Iida H
,
Tomita A
, et al.
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.
Int J Hematol. 2023.
PubMed
Google Scholar
C
Konuma T
,
Kondo T
,
Mizuno S
,
Doki N
,
Aoki J
,
Fukuda T
,
Tanaka M
,
Sawa M
,
Katayama Y
,
Uchida N
, et al.
Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
Konuma T
,
Yamasaki S
,
Ishiyama K
,
Mizuno S
,
Hayashi H
,
Uchida N
,
Shimabukuro M
,
Tanaka M
,
Kuriyama T
,
Onizuka M
, et al.
Comparison of allogeneic transplant outcomes between matched sibling donors and alternative donors in patients over 50 years of age with acute myeloid leukemia: 8/8 allele-matched unrelated donors and unrelated cord blood provide better leukemia-free surv
. Transplant Cell Ther. 2023.
PubMed
Google Scholar
Takamatsu H
,
Matsuda T
,
Mizuno S
,
Takahashi T
,
Fuchida S-I
,
Hanamura I
,
Kataoka K
,
Tsukada N
,
Matsumoto M
,
Hangaishi A
, et al.
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Haematologica. 2023.
PubMed
Google Scholar
A
Okada Y
,
Kimura F
,
Kurita N
,
Takahashi H
,
Shimazu Y
,
Mizuno S
,
Uchida N
,
Kataoka K
,
Hiramoto N
,
Ota S
, et al.
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Cytotherapy. 2023.
PubMed
Google Scholar